Trade Mark Journal No.2026/014 3 April 2026

UK00004357096 18 March 2026 (5)

XYVENTIX

International priority date claimed: 23 October 2025 (Taiwan) (114078223)

Class 5: Analgesics; Pharmaceutical preparations; Chemical preparations and reagents for use in the pharmaceutical, medical, and veterinary fields, namely, pharmaceutical preparations for emergency treatment, and for the monitoring and treatment of pain and cancer; Pharmaceutical preparations for use after cosmetic surgery; Anesthetics for surgical use or non-surgical use; Injectable suspension-type drug delivery carriers for facilitating the delivery of pharmaceuticals and analgesics; Pharmaceutical preparations for the treatment of joint diseases and pain; Pharmaceutical preparations, namely corticosteroids for the treatment of osteoarthritis pain; Liposome formulations containing preparations and substances for use in anesthesia and for the treatment and control of pain.

TAIWAN LIPOSOME CO., LTD.

Representative: Reddie & Grose LLP